
|Articles|July 28, 2020
Rely on Data, Not Lore to Meet Rising Demand
Author(s)Charles River
The COVID-19 pandemic has forced countless difficult decisions to be made in the face of unprecedented uncertainty. Patients, consumers, and industry professionals alike are looking for guidance, support, and answers. With increased demand on pharmaceutical manufacturers to develop a COVID-19 therapeutic alongside all the existing treatments that are still needed by millions, there follows the growing need for strict quality control processes, and the ability to test and release large volumes of newly manufactured vaccines.
Trending on Pharmaceutical Technology
1
Peptide Compounding Vote Raises New Questions for Drug Developers
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
PharmTech Weekly Roundup—July 24, 2026
4
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
5